Kathera Bioscience Inc. Email Format
Biotechnology ResearchNew Jersey, United States2-10 Employees
Kathera Bioscience Inc. operates in the biotechnology research sector with a focus on developing therapies for fungal infections, aiming to address the rising incidence of these diseases globally. The company seeks to create broad-spectrum treatments that overcome the limitations of existing options, targeting medical problems caused by fungal pathogens. Based in Union, New Jersey, Kathera Bioscience appears among small organizations in the biotechnology landscape, with operations centered on therapeutic development. The recent context mentions ongoing work in treating fungal infections, reflecting the company’s active direction in this disease area. The firm’s target market includes healthcare providers and patients affected by fungal diseases, seeking new, effective treatment options. Overall, Kathera Bioscience positions itself within biotech research pursuing novel therapies to fill gaps in current antifungal care.